The etiological significance of superantigen in periodontal disease and its possible role
The etiological significance of superantigen in periodontal disease and its possible role
批准号:
10671695
负责人:
RIKIISHI Hidemi
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We demonstrated previously that superantigen (SAg) enhances CD80 expression on human monocytes, whereas treatment with SAg in the presence of lipopolysaccharide (LPS) markedly decreases the percentage of CD80ィイD1+ィエD1 peripheral blood monocytes, indicating that the presence of low levels of CD80 on monocytes inhibits CD27 expression on SAg-activated T cells due to insufficient delivery of positive signals via CD28/CD80 interaction. To assess the role of LPS in this inhibition, the relationship between SAg-dependent apoptosis and regulation of CD80 expression of CD14ィイD1+ィエD1 monocytes was examines. SAg enhanced the annexin V-positive or PI-positive (propidium iodide) levels in monocytes, whereas LPS-treated monocytes were resistant to the apoptotic action of SAg. This SAg-induced killing was abrogated by antagonists anti-CD95 (Fas) and anti-CD95 ligand monoclonal antibodies, suggesting a CD95-based pathway of apoptosis. Furthermore, apoptosis of monocytes, preferentially CD80ィイD1-ィエD1 monocytes, was affected by high-level expression of CD95 by SAg, and the survival required down-regulation of CD95 expression by LPS over the SAg action. During these culture periods, the number of CD80ィイD1+ィエD1 monocytes was nearly constant. These observations strongly suggested that a small fraction of CD80ィイD1+ィエD1 monocytes is selectively resistant to CD95-based apoptosis, and the percentage of CD80ィイD1+ィエD1 monocytes increases through escape from SAg-induced preferential apoptosis, which is inhibited by addition of LPS.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
N.Horiuchi: "Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to β-streptococcal superantigens"Br. J. Dermatol.. 138. 229-235 (1998)
N. Horiuchi:“银屑病患者的外周血淋巴细胞对 β-链球菌超抗原反应低下”Br. J. Dermatol.. 138. 229-235 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Sugawara: "Heterogeneous expression and release of CD14 by human gingival fibroblast : characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide"Infect. Immun.. 66. 3043-3049 (1998)
S.Sukawara:“人牙龈成纤维细胞 CD14 的异质表达和释放:响应脂多糖的表征和 CD14 介导的白细胞介素 8 分泌”感染。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.HORIUCHI: "Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to β-streptococcal superantigens." British Journal of Dermatology. 138(2). 229-235 (1998)
N.HORIUCHI:“银屑病患者的外周血淋巴细胞对 β-链球菌超抗原反应低下。”英国皮肤病学杂志 138(2) (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.SUGAWARA: "Heterogeneous expression and release of CD14 by human gingival fibroblasts." Infection and Immunity. 66(7). 3043-3049 (1998)
S.SUGAWARA:“人牙龈成纤维细胞 CD14 的异质表达和释放。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N. Horiuchi: "Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to β-streptococcal superantigens"Br. J. Dermatol. 138(2). 229-235 (1998)
N. Horiuchi:“银屑病患者的外周血淋巴细胞对 β-链球菌超抗原反应低下”,Br. J. Dermatol,138(2)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Mechanisms of Taxotere-induced apoptosis in or a squamous cell carcinoma.
-
批准号:16390577
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.66万
-
财政年份:2004
-
负责人:RIKIISHI Hidemi
-
依托单位:
Selective apoptosis during treatment with superantigen and lipopolysaccharide
-
批准号:14571726
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:2002
-
负责人:RIKIISHI Hidemi
-
依托单位:
Inhibition of superantigen-induced apoptosis by LPS
-
批准号:12671759
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:RIKIISHI Hidemi
-
依托单位:
Induction of cytokines by oral bacterial stimulation and its arthropathic properties
-
批准号:02670824
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1990
-
负责人:RIKIISHI Hidemi
-
依托单位:
国内基金
海外基金
Lipopolysaccharide 调节 Toll-like receptor 4 介导促进心肌样细胞存活时间的实验研究
-
批准号:30872544
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2008
-
负责人:陈亦江
-
依托单位: